# K170067: Easyret

- Pathway: 510(k) (Traditional)
- Applicant: Quantel Medical
- Decided: Jul 25, 2017 after 197 days
- Product code: HQF (Laser, Ophthalmic)
- Device class: 2
- Regulation: 21 CFR 886.4390
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 9 generations back to K894841 (1989). 30 ancestors in all.
No later device cites it as a predicate yet.
0 of 31 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K120825: Supra Scan Delivery System, Quantel Medical (2012) Summary page 4.

## Indications for use
The Easyret® is indicated for use in the treatment of ocular pathology of anterior and posterior segments including, retinal photocoagulation, pan retinal photocoagulation for vascular and structural abnormalities of the retina and uvea including: - Proliferative and severe nonproliferative diabetic retinopathy, - Choroidal neovascularization - Branch retinal vein occlusion - Treatment of choroidal neovascularization associated with wet age-related macular degeneration - Retinal tears and detachments, - Certain forms of macular edema -Retinopathy of Prematurity - Iridotomy in angle closure glaucoma and trabeculoplasty in open angle glaucoma

Source page: https://510kreport.com/device/K170067
Methodology: https://510kreport.com/methodology